Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms

BACKGROUND: Oncolytic virotherapy is an upcoming treatment option for many tumor entities. But so far, a first oncolytic virus only was approved for advanced stages of malignant melanomas. Neuroendocrine tumors (NETs) constitute a heterogenous group of tumors arising from the neuroendocrine system a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kloker, Linus D., Berchtold, Susanne, Smirnow, Irina, Beil, Julia, Krieg, Andreas, Sipos, Bence, Lauer, Ulrich M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339398/
https://www.ncbi.nlm.nih.gov/pubmed/32631270
http://dx.doi.org/10.1186/s12885-020-07121-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339398/
https://www.ncbi.nlm.nih.gov/pubmed/32631270
http://dx.doi.org/10.1186/s12885-020-07121-8

Ejemplares similares